The present study used two mouse models for breast cancer bone metastasis (intra-tibial and intra-iliac injection of cancer cells) to demonstrate that a single subcutaneous injection of bone-targeted PTHrP antagonists effectively inhibits breast cancer bone metastases. This evidence concerns the gene PTHLH and breast carcinoma.